Professor, Eppley InstitutePhone: 402-559 3793
Email: Amar Natarajan
Ph.D., University of Vermont
Our research interests are focused on the discovery and development of small molecule inhibitors to perturb disease relevant biomolecules. We are also interested in using these small molecule inhibitors to understand the role of the disease relevant biomolecules in signal transduction. Small molecule inhibitors for these studies are identified and developed from a variety of sources, which include screening chemical libraries, natural products and conformationally constrained mimics. Synthetic chemistry spearheads our research program, however, biology and computational methods are used synergistically in our quest for a better comprehension of the cellular events contiguous to disease relevant proteins.
Targeting the phosphoprotein binding site on BRCT(BRCA1) / Cbl (TKB)
Assay development and high throughput screening
Methods development, synthesis of focused libraries and natural product syntheses
On the path from bench to bedside – Studies in mouse models